386 related articles for article (PubMed ID: 31841061)
1. Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer.
Xu H; Chen R; Jiang C; You S; Zhu Q; Li Y; Li S; Zha X; Wang J
J Vasc Access; 2020 Sep; 21(5):609-614. PubMed ID: 31841061
[TBL] [Abstract][Full Text] [Related]
2. PICC-PORT totally implantable vascular access device in breast cancer patients undergoing chemotherapy.
Bertoglio S; Cafiero F; Meszaros P; Varaldo E; Blondeaux E; Molinelli C; Minuto M
J Vasc Access; 2020 Jul; 21(4):460-466. PubMed ID: 31674857
[TBL] [Abstract][Full Text] [Related]
3. A Comparison Between Upper Arm and Chest for Optimal Site of Totally Implanted Venous Access Ports in Patients with Female Breast Cancer.
Yang SS; Ahn MS
Ann Vasc Surg; 2018 Jul; 50():128-134. PubMed ID: 29481918
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy.
Hong S; Seo TS; Song MG; Seol HY; Suh SI; Ryoo IS
J Vasc Access; 2019 Mar; 20(2):134-139. PubMed ID: 29923460
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of peripherally inserted central venous catheters in acute cardiac care management.
Poletti F; Coccino C; Monolo D; Crespi P; Ciccioli G; Cordio G; Seveso G; De Servi S
J Vasc Access; 2018 Sep; 19(5):455-460. PubMed ID: 29514546
[TBL] [Abstract][Full Text] [Related]
6. Effect of catheter diameter on left innominate vein in breast cancer patients after totally implantable venous access port placement.
Song MG; Seo TS; Kim YH; Cho SB; Chung HH; Lee SH; Jung E
J Vasc Access; 2018 Nov; 19(6):615-619. PubMed ID: 29560786
[TBL] [Abstract][Full Text] [Related]
7. Infection of totally implantable venous access devices: A review of the literature.
Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
[TBL] [Abstract][Full Text] [Related]
8. Common and uncommon complications of totally implantable central venous ports: a pictorial essay.
Perdikakis E; Kehagias E; Tsetis D
J Vasc Access; 2012; 13(3):345-50. PubMed ID: 22307469
[TBL] [Abstract][Full Text] [Related]
9. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
[TBL] [Abstract][Full Text] [Related]
10. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
[TBL] [Abstract][Full Text] [Related]
11. The "Arm-to-Chest Tunneling" technique: A modified technique for arm placement of implantable ports or central catheters.
Kehagias E; Tsetis D
J Vasc Access; 2019 Nov; 20(6):771-777. PubMed ID: 30939969
[TBL] [Abstract][Full Text] [Related]
12. Centrally inserted tunnelled peripherally inserted central catheter: Off-label use for venous access in oncology patients.
Lingegowda D; Gehani A; Sen S; Mukhopadhyay S; Ghosh P
J Vasc Access; 2020 Sep; 21(5):773-777. PubMed ID: 32133909
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute.
Mori Y; Nagayama S; Kawamura J; Hasegawa S; Tanaka E; Okabe H; Takeuchi M; Sonobe M; Matsumoto S; Kanai M; Muto M; Chiba T; Sakai Y
Int J Clin Oncol; 2016 Jun; 21(3):474-82. PubMed ID: 26507141
[TBL] [Abstract][Full Text] [Related]
14. A novel incision technique of a totally implanted venous access port in the upper arm for patients with breast cancer.
Song X; Chen S; Dai Y; Sun Y; Lin X; He J; Xu R
World J Surg Oncol; 2023 May; 21(1):162. PubMed ID: 37237419
[TBL] [Abstract][Full Text] [Related]
15. A comparison of infections and complications in central venous catheters in adults with solid tumours.
Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S
J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809
[TBL] [Abstract][Full Text] [Related]
16. Chinesization of the quality of life assessment, venous device-port, and its reliability and validity tests for patients with breast cancer.
Liu Y; Xu L; Jiang M; Chen B; Jing L; Zhang L; Su P; Jin F; Mao X
J Vasc Access; 2020 Nov; 21(6):983-989. PubMed ID: 32372676
[TBL] [Abstract][Full Text] [Related]
17. Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients: single center experience.
Charvát J; Linke Z; Horáèková M; Prausová J
Support Care Cancer; 2006 Nov; 14(11):1162-5. PubMed ID: 16596418
[TBL] [Abstract][Full Text] [Related]
18. Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT.
Wu O; McCartney E; Heggie R; Germeni E; Paul J; Soulis E; Dillon S; Ryan C; Sim M; Dixon-Hughes J; Agarwal R; Bodenham A; Menne T; Jones B; Moss J
Health Technol Assess; 2021 Jul; 25(47):1-126. PubMed ID: 34318743
[TBL] [Abstract][Full Text] [Related]
19. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B
Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444
[TBL] [Abstract][Full Text] [Related]
20. Peripherally inserted central catheters in the treatment of children with cancer: Results of a multicenter study.
Rykov MY; Zaborovskij SV; Shvecov AN; Shukin VV
J Vasc Access; 2018 Jul; 19(4):378-381. PubMed ID: 29546772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
